Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
clinical trials
boston blog main
boston top stories
san francisco blog main
cancer
fda
national top stories
new york blog main
san francisco top stories
boston
deals
investing
ipo
new york top stories
cancer drugs
biotech ipos
europe blog main
medical device
national
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
san diego blog main
sanofi
startups
drug discovery
europe top stories
multiple myeloma
novartis
san diego top stories
san francisco
third rock ventures
venture capital
abbvie
acute myeloid leukemia
akouos
biogen
What
ipo
19
×
medicines
drug
biotech
developing
million
new
raised
therapeutics
companies
company
cancer
life
public
research
bio
clinical
genetic
ipos
plans
raises
science
tests
treat
way
week
activity
based
brings
covid
days
diseases
dyne
experimental
fda
fund
hasn’t
lead
leading
markets
Language
unset
19
×
Current search:
ipo
×
unset
×
@techinasia.com
1 year ago
In 50 Words: Genesis MedTech plans Hong Kong IPO, may raise up to $500m
@techcrunch.com
3 years ago
Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics
@techcrunch.com
3 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs